Skip to main content
. 2024 Jan 18;26:13. doi: 10.1186/s13058-024-01768-y

Fig. 4.

Fig. 4

Forest plot. Cox regression multivariate analysis of the impact of various variables on progression-free survival in patients with HR+/HER2− mBC including A endocrine therapy combined with CDK4/6i (Endocrine + CDK4/6i) or B chemotherapy. HR, hormone receptor; CTCs, circulating tumor cells; cfDNA, cell-free DNA; *p < 0.05, **p < 0.01, ***p < 0.005